List

Dr Georges Janssens 

Laboratory Genetic Metabolic Diseases, Amsterdam University Medical Centers

Assistant Professor

Text

<h3 style="white-space:pre-line">Bio</h3>
Georges Janssens is Assistant Professor in the Laboratory Genetic Metabolic Diseases, at the Amsterdam UMC, location AMC in The Netherlands. His work is focused on multi-omics data integration studying the molecular determinants of healthy aging, and the development of neutraceuticals and pharmaceuticals to promote health during aging. His research education has taken place in California, the UK, Sweden, and the Netherlands. During his postdoctoral work at the Karolinska institute in Stockholm, he pioneered transcriptome-based machine-learning enabled drug screening, an approach he continues to expand upon today in his independent research line. Dr. Janssens has been awarded several prestigious fellowships including the FEBS (2017) and the VENI (2019). He has authored nearly 50 publications on aging, with recent first or corresponding authorships in journals including Cell Metabolism, Cell Reports, Aging Cell, EMBO Molecular Medicine, and many more. He writes a popular-science blog that distills myths on aging (AgingIsBeautiful.com) and is passionate to develop healthy aging diagnostics and interventions that are accessible to the public. 
<h3>About the talk</h3>
Finding Effective and Safe Supplements in Healthy Longevity  
Public attention and interest for longevity interventions are growing. Supplements—also known as neutraceuticals—may provide the easiest route to granting access of longevity interventions to the pubic, however, it is unlikely that most interventions identified in model organisms will translate to humans, or that every intervention will benefit each person equally. In the worst case, even detrimental health effects may occur. Therefore, finding supplements that are both effective and safe for healthy longevity is of paramount importance. In this work, we illustrate how to identify candidate longevity neutraceuticals using population data in humans, an approach we are currently employing.